Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation
New England Journal of Medicine · 23.10.2025 · 393 (16) · 1578-1588
DOI: 10.1056/nejmoa2507532 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 23.10.2025. Verfasst von Gilles Lemesle und 20 weiteren Autor:innen. Beteiligte Einrichtung: Heart and Lung Institute, University Hospital of Lille, Centre Hospitalier Universitaire (CHU) Lille, Lille, France. Hauptthemen laut MEDLINE: Anticoagulants, Aspirin, Platelet Aggregation Inhibitors, Coronary Disease. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Ministère des Affaires Sociales et de la Santé, Bayer HealthCare, French Ministry of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Heart and Lung Institute, University Hospital of Lille, Centre Hospitalier Universitaire (CHU) Lille, Lille, France.
- Institut Pasteur de Lille, INSERM Unité 1011, Lille, France.
- Université de Lille, Lille, France.
- French Alliance for Cardiovascular Trials, Paris.
- Cardiology Department, CHU Brest, Brest, France.
- INSERM Unité Mixte de Recherche (UMR) 1304-Groupe d'Études Tumeurs et Biothérapies Oncologiques (GETBO) Brest, France.
ORCID-Profile: Philippe Gabriel Steg
Förderung
- Ministère des Affaires Sociales et de la Santé
- Bayer HealthCare
- French Ministry of Health
Zitieren
APA
Lemesle, G., Didier, R., Steg, P. G., Simon, T., Montalescot, G., Danchin, N., Bauters, C., Blanchard, D., Bouleti, C., Angoulvant, D., Andrieu, S., Vanzetto, G., Kerneis, M., Decalf, V., Puymirat, E., Mottier, D., Diallo, A., Vicaut, E., Gilard, M., …, & AQUATIC Trial Investigators (2025). Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation. New England Journal of Medicine, 393(16), 1578-1588. https://doi.org/10.1056/nejmoa2507532
Vancouver
Lemesle G, Didier R, Steg PG, Simon T, Montalescot G, Danchin N, et al. Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation. New England Journal of Medicine. 2025;393(16):1578-1588. doi:10.1056/nejmoa2507532
BibTeX
@article{Lemesle2025,
author = {Lemesle, Gilles and Didier, Romain and Steg, Philippe Gabriel and Simon, Tabassome and Montalescot, Gilles and Danchin, Nicolas and Bauters, Christophe and Blanchard, Didier and Bouleti, Claire and Angoulvant, Denis and Andrieu, Stéphane and Vanzetto, Gérald and Kerneis, Mathieu and Decalf, Véronique and Puymirat, Etienne and Mottier, Dominique and Diallo, Abdourahmane and Vicaut, Eric and Gilard, Martine and Cayla, Guillaume and AQUATIC Trial Investigators, AQUATIC Trial Investigators},
title = {Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation},
journal = {New England Journal of Medicine},
year = {2025},
volume = {393},
number = {16},
pages = {1578--1588},
doi = {10.1056/nejmoa2507532}
}
EUVIMED